Loretto Callaghan is an experienced non-executive director and former CEO with senior executive and board-level experience in complex, highly regulated environments, including biopharmaceuticals, biotechnology, medical devices, and healthcare delivery.

She served as CEO and Country President at Novartis Ireland for 14 years, and she was a Board Member of Beaumont Hospital, where she was chair of the Clinical Governance and Risk Committee.

A Chartered Director, Loretto holds a Master of Science degree from Trinity College Dublin, a Bachelor of Science degree from University College Dublin, and a Professional Certificate in Responsible and Sustainable Finance from the Institute of Banking. She has also completed executive education programmes in Healthcare Systems Excellence at the T.H. Chan School of Public Health, Finance at Harvard Business School and Advanced Leadership at Tuck School of Business.

She currently serves on the Board of An Bord Iascaigh Mhara and is a member of the Governance Advisory Council of the Corporate Governance Institute in Ireland.